aluates Reports

$ 0.0

Automative

Global Autologous CAR-T Cell Therapy Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-20L18315

Global Autologous CAR T Cell Therapy Market Research Report 2024

BUY CHAPTERS

Global Autologous CAR-T Cell Therapy Market Research Report 2025

Code: QYRE-Auto-20L18315

Report

April 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead (Kite Pharma)

Bristol–Myers Squibb

Novartis

Fosun Kite Biotechnology

JW Therapeutics

Bluebird bio

Juventas Cell Therapy

Legend Biotech

IASO Bio

CARsge

Autologous CAR-T Cell Therapy Market Size

The global market for Autologous CAR-T Cell Therapy was valued at US$ 4437 million in the year 2024 and is projected to reach a revised size of US$ 17630 million by 2031, growing at a CAGR of 22.1% during the forecast period.

Autologous CAR-T Cell Therapy Market

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

Cell immunotherapy techniques, represented by chimeric antigen receptor T-cell immunotherapy (CAR-T therapy), express CAR fusion proteins on the surface of T cells through genetic engineering technology. The CAR extracellular antigen recognition region (one of the components of CAR cells, responsible for recognizing tumor cell surface antigens) can specifically recognize tumor antigens and transmit signals into cells to activate T cells, achieving proliferation and targeted killing of tumor cells. CAR-T therapy has shown breakthrough efficacy and enormous potential for development and market prospects for cancer patients who are unable to cope with traditional treatments. CAR-T cells are divided into autologous and allogeneic CAR-T cells. At present, CAR-T therapy mainly uses autologous CAR-T cells.

In recent years, the progress of autologous CAR-T cell therapy in hematological tumors has inspired scientists to extend this technology to the treatment of solid tumors. However, the current progress in the treatment of solid tumors is relatively slow. But in the future, with the discovery of more targets and the development of clinical trials, solid tumors are expected to become the main treatment area for CAR-T. At present, JW (Cayman) Therapeutics is laying out more innovative products to officially enter the field of cell therapy for solid tumors.

This report aims to provide a comprehensive presentation of the global market for Autologous CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous CAR-T Cell Therapy.

The Autologous CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autologous CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autologous CAR-T Cell Therapy Market Report

Report Metric	Details
Report Name	Autologous CAR-T Cell Therapy Market
Accounted market size in year	US$ 4437 million
Forecasted market size in 2031	US$ 17630 million
CAGR	22.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Target: CD19 Target: BCMA
Segment by Application	Hematological Tumors Solid Tumor
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead (Kite Pharma), Bristol Myers Squibb, Fosun Kite Biotechnology, JW Therapeutics, Bluebird Bio, IASO Bio, Juventas Cell Therapy, Legend Biotech, CARsge
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Autologous CAR-T Cell Therapy Market growing?

Ans: The Autologous CAR-T Cell Therapy Market witnessing a CAGR of 22.1% during the forecast period 2025-2031.

What is the Autologous CAR-T Cell Therapy Market size in 2031?

Ans: The Autologous CAR-T Cell Therapy Market size in 2031 will be US$ 17630 million.

Who are the main players in the Autologous CAR-T Cell Therapy Market report?

Ans: The main players in the Autologous CAR-T Cell Therapy Market are Novartis, Gilead (Kite Pharma), Bristol Myers Squibb, Fosun Kite Biotechnology, JW Therapeutics, Bluebird Bio, IASO Bio, Juventas Cell Therapy, Legend Biotech, CARsge

What are the Application segmentation covered in the Autologous CAR-T Cell Therapy Market report?

Ans: The Applications covered in the Autologous CAR-T Cell Therapy Market report are Hematological Tumors, Solid Tumor

What are the Type segmentation covered in the Autologous CAR-T Cell Therapy Market report?

Ans: The Types covered in the Autologous CAR-T Cell Therapy Market report are Target: CD19, Target: BCMA

Recommended Reports

CAR-T Cell Therapy

Cellular Immunotherapies

Autologous Cell Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Target: CD19

1.2.3 Target: BCMA

1.3 Market by Application

1.3.1 Global Autologous CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hematological Tumors

1.3.3 Solid Tumor

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Autologous CAR-T Cell Therapy Market Perspective (2020-2031)

2.2 Global Autologous CAR-T Cell Therapy Growth Trends by Region

2.2.1 Global Autologous CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Autologous CAR-T Cell Therapy Historic Market Size by Region (2020-2025)

2.2.3 Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)

2.3 Autologous CAR-T Cell Therapy Market Dynamics

2.3.1 Autologous CAR-T Cell Therapy Industry Trends

2.3.2 Autologous CAR-T Cell Therapy Market Drivers

2.3.3 Autologous CAR-T Cell Therapy Market Challenges

2.3.4 Autologous CAR-T Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue

3.1.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue (2020-2025)

3.1.2 Global Autologous CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top Autologous CAR-T Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Autologous CAR-T Cell Therapy Revenue

3.4 Global Autologous CAR-T Cell Therapy Market Concentration Ratio

3.4.1 Global Autologous CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Autologous CAR-T Cell Therapy Revenue in 2024

3.5 Global Key Players of Autologous CAR-T Cell Therapy Head office and Area Served

3.6 Global Key Players of Autologous CAR-T Cell Therapy, Product and Application

3.7 Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Autologous CAR-T Cell Therapy Breakdown Data by Type

4.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Type (2020-2025)

4.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)

5 Autologous CAR-T Cell Therapy Breakdown Data by Application

5.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Application (2020-2025)

5.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Autologous CAR-T Cell Therapy Market Size (2020-2031)

6.2 North America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)

6.4 North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Autologous CAR-T Cell Therapy Market Size (2020-2031)

7.2 Europe Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)

7.4 Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Autologous CAR-T Cell Therapy Market Size (2020-2031)

8.2 Asia-Pacific Autologous CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Autologous CAR-T Cell Therapy Market Size (2020-2031)

9.2 Latin America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)

9.4 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Autologous CAR-T Cell Therapy Market Size (2020-2031)

10.2 Middle East & Africa Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Autologous CAR-T Cell Therapy Introduction

11.1.4 Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Gilead (Kite Pharma)

11.2.1 Gilead (Kite Pharma) Company Details

11.2.2 Gilead (Kite Pharma) Business Overview

11.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Introduction

11.2.4 Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.2.5 Gilead (Kite Pharma) Recent Development

11.3 Bristol Myers Squibb

11.3.1 Bristol Myers Squibb Company Details

11.3.2 Bristol Myers Squibb Business Overview

11.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Introduction

11.3.4 Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.3.5 Bristol Myers Squibb Recent Development

11.4 Fosun Kite Biotechnology

11.4.1 Fosun Kite Biotechnology Company Details

11.4.2 Fosun Kite Biotechnology Business Overview

11.4.3 Fosun Kite Biotechnology Autologous CAR-T Cell Therapy Introduction

11.4.4 Fosun Kite Biotechnology Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.4.5 Fosun Kite Biotechnology Recent Development

11.5 JW Therapeutics

11.5.1 JW Therapeutics Company Details

11.5.2 JW Therapeutics Business Overview

11.5.3 JW Therapeutics Autologous CAR-T Cell Therapy Introduction

11.5.4 JW Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.5.5 JW Therapeutics Recent Development

11.6 Bluebird Bio

11.6.1 Bluebird Bio Company Details

11.6.2 Bluebird Bio Business Overview

11.6.3 Bluebird Bio Autologous CAR-T Cell Therapy Introduction

11.6.4 Bluebird Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.6.5 Bluebird Bio Recent Development

11.7 IASO Bio

11.7.1 IASO Bio Company Details

11.7.2 IASO Bio Business Overview

11.7.3 IASO Bio Autologous CAR-T Cell Therapy Introduction

11.7.4 IASO Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.7.5 IASO Bio Recent Development

11.8 Juventas Cell Therapy

11.8.1 Juventas Cell Therapy Company Details

11.8.2 Juventas Cell Therapy Business Overview

11.8.3 Juventas Cell Therapy Autologous CAR-T Cell Therapy Introduction

11.8.4 Juventas Cell Therapy Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.8.5 Juventas Cell Therapy Recent Development

11.9 Legend Biotech

11.9.1 Legend Biotech Company Details

11.9.2 Legend Biotech Business Overview

11.9.3 Legend Biotech Autologous CAR-T Cell Therapy Introduction

11.9.4 Legend Biotech Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.9.5 Legend Biotech Recent Development

11.10 CARsge

11.10.1 CARsge Company Details

11.10.2 CARsge Business Overview

11.10.3 CARsge Autologous CAR-T Cell Therapy Introduction

11.10.4 CARsge Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)

11.10.5 CARsge Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gilead (Kite Pharma)

Bristol–Myers Squibb

Novartis

Fosun Kite Biotechnology

JW Therapeutics

Bluebird bio

Juventas Cell Therapy

Legend Biotech

IASO Bio

CARsge

List of Tables

Table 1. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Target: CD19

Table 3. Key Players of Target: BCMA

Table 4. Global Autologous CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Autologous CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Autologous CAR-T Cell Therapy Market Share by Region (2020-2025)

Table 8. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Autologous CAR-T Cell Therapy Market Share by Region (2026-2031)

Table 10. Autologous CAR-T Cell Therapy Market Trends

Table 11. Autologous CAR-T Cell Therapy Market Drivers

Table 12. Autologous CAR-T Cell Therapy Market Challenges

Table 13. Autologous CAR-T Cell Therapy Market Restraints

Table 14. Global Autologous CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Autologous CAR-T Cell Therapy Market Share by Players (2020-2025)

Table 16. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2024)

Table 17. Ranking of Global Top Autologous CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Autologous CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Autologous CAR-T Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of Autologous CAR-T Cell Therapy, Product and Application

Table 21. Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Autologous CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Autologous CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis Autologous CAR-T Cell Therapy Product

Table 49. Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Gilead (Kite Pharma) Company Details

Table 52. Gilead (Kite Pharma) Business Overview

Table 53. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product

Table 54. Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 55. Gilead (Kite Pharma) Recent Development

Table 56. Bristol Myers Squibb Company Details

Table 57. Bristol Myers Squibb Business Overview

Table 58. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product

Table 59. Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 60. Bristol Myers Squibb Recent Development

Table 61. Fosun Kite Biotechnology Company Details

Table 62. Fosun Kite Biotechnology Business Overview

Table 63. Fosun Kite Biotechnology Autologous CAR-T Cell Therapy Product

Table 64. Fosun Kite Biotechnology Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 65. Fosun Kite Biotechnology Recent Development

Table 66. JW Therapeutics Company Details

Table 67. JW Therapeutics Business Overview

Table 68. JW Therapeutics Autologous CAR-T Cell Therapy Product

Table 69. JW Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 70. JW Therapeutics Recent Development

Table 71. Bluebird Bio Company Details

Table 72. Bluebird Bio Business Overview

Table 73. Bluebird Bio Autologous CAR-T Cell Therapy Product

Table 74. Bluebird Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 75. Bluebird Bio Recent Development

Table 76. IASO Bio Company Details

Table 77. IASO Bio Business Overview

Table 78. IASO Bio Autologous CAR-T Cell Therapy Product

Table 79. IASO Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 80. IASO Bio Recent Development

Table 81. Juventas Cell Therapy Company Details

Table 82. Juventas Cell Therapy Business Overview

Table 83. Juventas Cell Therapy Autologous CAR-T Cell Therapy Product

Table 84. Juventas Cell Therapy Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 85. Juventas Cell Therapy Recent Development

Table 86. Legend Biotech Company Details

Table 87. Legend Biotech Business Overview

Table 88. Legend Biotech Autologous CAR-T Cell Therapy Product

Table 89. Legend Biotech Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 90. Legend Biotech Recent Development

Table 91. CARsge Company Details

Table 92. CARsge Business Overview

Table 93. CARsge Autologous CAR-T Cell Therapy Product

Table 94. CARsge Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)

Table 95. CARsge Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Autologous CAR-T Cell Therapy Picture

Figure 2. Global Autologous CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Autologous CAR-T Cell Therapy Market Share by Type: 2024 VS 2031

Figure 4. Target: CD19 Features

Figure 5. Target: BCMA Features

Figure 6. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Autologous CAR-T Cell Therapy Market Share by Application: 2024 VS 2031

Figure 8. Hematological Tumors Case Studies

Figure 9. Solid Tumor Case Studies

Figure 10. Autologous CAR-T Cell Therapy Report Years Considered

Figure 11. Global Autologous CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Autologous CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Autologous CAR-T Cell Therapy Market Share by Region: 2024 VS 2031

Figure 14. Global Autologous CAR-T Cell Therapy Market Share by Players in 2024

Figure 15. Global Autologous CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Autologous CAR-T Cell Therapy Revenue in 2024

Figure 17. North America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 19. United States Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 23. Germany Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Autologous CAR-T Cell Therapy Market Share by Region (2020-2031)

Figure 31. China Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 39. Mexico Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)

Figure 43. Turkey Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 47. Gilead (Kite Pharma) Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 48. Bristol Myers Squibb Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 49. Fosun Kite Biotechnology Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 50. JW Therapeutics Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 51. Bluebird Bio Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 52. IASO Bio Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 53. Juventas Cell Therapy Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 54. Legend Biotech Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 55. CARsge Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CAR T Cell Service Market Research Report 2024

Global CAR T Cell Development Service Market Research Report 2024

Global CAR T Cell Manufacturing Service Market Research Report 2024

Global CAR T Therapy for Hematological Cancer Market Research Report 2024

CAR T Cellular Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAR T cell Therapy Drug Market Research Report 2025

Global CAR T Cell Therapy Agents Market Research Report 2025

Global Drug based on CAR T Cell Market Research Report 2025

Global Drugs Based on CAR T cell Market Research Report 2025

Cancer Drug based on CAR T Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CAR T Cell Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CD19 targeted CAR T Cell Therapy Market Research Report 2024

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global T Cell Immunotherapy Market Research Report 2025

Global BCMA targeted CAR T Cell Therapy Market Research Report 2025

Global TCR T Cellular Immunotherapy Market Research Report 2024

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autologous Cell Therapy Products Market Research Report 2024

Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions